T. Rowe Price Associates’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-571,115
Closed -$38.9M 3053
2022
Q3
$38.9M Sell
571,115
-2,535,686
-82% -$173M 0.01% 725
2022
Q2
$99.3M Sell
3,106,801
-74,498
-2% -$2.38M 0.01% 663
2022
Q1
$110M Sell
3,181,299
-79,386
-2% -$2.75M 0.01% 698
2021
Q4
$95.4M Sell
3,260,685
-147,309
-4% -$4.31M 0.01% 783
2021
Q3
$86.8M Sell
3,407,994
-352,201
-9% -$8.97M 0.01% 815
2021
Q2
$132M Sell
3,760,195
-113,871
-3% -$3.99M 0.01% 689
2021
Q1
$158M Sell
3,874,066
-189,057
-5% -$7.7M 0.02% 626
2020
Q4
$176M Sell
4,063,123
-146,011
-3% -$6.32M 0.02% 556
2020
Q3
$232M Sell
4,209,134
-351,309
-8% -$19.4M 0.03% 451
2020
Q2
$288M Sell
4,560,443
-492,139
-10% -$31.1M 0.04% 392
2020
Q1
$258M Sell
5,052,582
-603,603
-11% -$30.8M 0.04% 356
2019
Q4
$450M Buy
5,656,185
+1,077,160
+24% +$85.6M 0.06% 320
2019
Q3
$222M Buy
4,579,025
+402,083
+10% +$19.5M 0.03% 431
2019
Q2
$220M Buy
4,176,942
+572,808
+16% +$30.1M 0.03% 445
2019
Q1
$191M Buy
3,604,134
+461,588
+15% +$24.4M 0.03% 484
2018
Q4
$129M Buy
3,142,546
+154,539
+5% +$6.34M 0.02% 542
2018
Q3
$114M Buy
2,988,007
+240,410
+9% +$9.14M 0.02% 628
2018
Q2
$124M Buy
2,747,597
+214,308
+8% +$9.69M 0.02% 603
2018
Q1
$122M Buy
2,533,289
+601,727
+31% +$29.1M 0.02% 590
2017
Q4
$76M Buy
1,931,562
+1,264,013
+189% +$49.7M 0.01% 724
2017
Q3
$20.7M Buy
667,549
+111,723
+20% +$3.47M ﹤0.01% 1163
2017
Q2
$15.2M Buy
+555,826
New +$15.2M ﹤0.01% 1240
2017
Q1
Sell
-342,573
Closed -$4.95M 2604
2016
Q4
$4.95M Buy
+342,573
New +$4.95M ﹤0.01% 1421